Gabapentin as add-on therapy in focal epilepsy: A computerized EEG study

Clinical Neurophysiology

Volumn 111, Issue 2, 2000, Pages 311-317

  Mattia, D ^a   Spanedda, F ^a   Bassetti, M A ^b   Romigi, A ^b   Placidi, F ^b   Marciani, M G ^b  

^a IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Computerised EEG; Epilepsy; Gabapentin

Indexed keywords

CARBAMAZEPINE; CLOBAZAM; CLONAZEPAM; GABAPENTIN; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; VALPROIC ACID;

ADD ON THERAPY; ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG RESISTANCE; ELECTROENCEPHALOGRAM; FEMALE; FOCAL EPILEPSY; HUMAN; MALE; PRIORITY JOURNAL; SLOW BRAIN WAVE;

ACETIC ACIDS; ADOLESCENT; ADULT; AMINES; ANTICONVULSANTS; BRAIN; BRAIN MAPPING; CYCLOHEXANECARBOXYLIC ACIDS; ELECTROENCEPHALOGRAPHY; EPILEPSIES, PARTIAL; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; MIDDLE AGED;

EID: 0033987031     PISSN: 13882457     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1388-2457(99)00240-0     Document Type: Article

References (23)

1. Abou-Khalil B., McLean M., Castro O., Courville K. Gabapentin in the treatment of refractory partial seizures. Epilepsia. 31:1990;644.
2. Anhut H., Ashman P.J., Feuerstein T.J., Quebe-Fehling E., Saunders M., Baron B.A. Long-term safety and efficacy of gabapentin (Neurontin) as add-on therapy in patients with refractory partial seizures. J Epilepsy. 8:1995;44-50.
3. Bartoszyk G.D., Meyerson N., Reimann W., Satzinger G., von Hodenberg A. Gabapentin. Meldrum B.S., Porter R.J. Current problems in epilepsy: new anticonvulsant drugs. 1986;147-164 John Libbey and Company, London.
4. Bergey G.K., Morris H.H., Rosenfeld W., Blume W.T., Penovich P.E., Morrell M.J., Leiderman D.B., Crockatt J.G., LaMoreaux L. Gabapentin monotherapy: I. An 8-day, double-blind, dose-controlled, multicenter study in hospitalised patients with refractory complex partial or secondarily generalised seizures. Neurology. 49:1997;739-745.
5. Beydoun A., Fakhoury T., Nasreddine W., Abou-Khalil B. Conversion to high dose gabapentin monotherapy in patients with medically refractory partial epilepsy. Epilepsia. 39:(2):1998;188-193.
6. Chadwick D., Anhut H., Murray G., Greiner M., Alexander J. International Gabapentin Monotherapy Study Group. Gabapentin (GBP; Neurontin) monotherapy in patients with newly-diagnosed epilepsy: results of a double-blind fixed-dose study comparing three dosages of gabapentin and open-label carbamazepine [Abstract]. Epilepsia. 38 (suppl 3):1997;34.
7. Crawford P., Ghadiali E., Lane R., Blumhardt L., Chadwick D. Gabapentin as an antiepileptic drug in man. J Neurol Neurosurg Psychiatry. 50:1987;682-686.
8. Dodrill C.B., Wilensky A.J., Ojemann L.M., Temkin N.R., Shellenberger K., Wallace J. Neuropsychological, mood and psychosocial effects of gabapentin. Epilepsia. 33 (suppl 3):1992;117.
9. Gasser T., Bacher P., Mocks J. Transformation towards the normal distribution of broad band spectral parameters of the EEG. Electroenceph clin Neurophysiol. 53:1982;119-124.
10. Gotman J. Relationships between triggered seizures, spontaneous seizures and interictal spiking in the kindling model of epilepsy. Exp Neurol. 84:1984;259-264.
11. Gotman J. Relationship between interictal spiking and seizures: human and experimental evidence. Can J Neurol Sci. 18:(4):1991;537-576.
12. Gotman J., Marciani M.G. Electroencephalographic spiking activity, drug levels, and seizure occurrence in epileptic patients. Ann Neurol. 17:1985;597-603.
13. Handforth A., Treiman D.M. Efficacy and tolerance of long-term, high-dose gabapentin: additional observations. Epilepsia. 35:(5):1994;1032-1037.
14. 3H]gabapentin to a novel site in rat brain: autoradiographic studies. Eur J Pharmacol. 244:1993;303-309.
15. Leach J.P., Girvan J., Paul A., Brodie M.J. Gabapentin and cognition: a double blind, dose ranging, placebo controlled study in refractory epilepsy. J Neurol Neurosurg Psychiatry. 62:1997;372-376.
16. Leppik I.E., Shellenberger M.K., Anhut H. Two open-label, multicenter studies of the safety and efficacy of gabapentin as add-on therapy in patients with refractory partial seizures. Epilepsia. 33 (suppl 3):1992;117.
17. Ojemann L.M., Wilensky A.J., Temkin N.R., Chmelir T., Ricker B.A., Wallace J. Long-term treatment with gabapentin for partial epilepsy. Epilepsy Res. 13:1992;159-165.
18. Saletu B., Grünberger J., Linzmayer L. Evaluation of encephalotropic and psychotropic properties of gabapentin in man by pharmaco-EEG and psychometry. Int J Clin Pharmacol Ther Toxicol. 24:(7):1986;362-373.
19. Sivenius J., Kälviäinen R., Ylinen A., Riekkinen P. Double-blind study of gabapentin in the treatment of partial seizures. Epilepsia. 32:(4):1991;539-542.
20. 3H]gabapentin binding to a novel site in rat brain: homogenate binding studies. Eur J Pharmacol. 244:1993;293-301.
21. Gabapentin as add-on therapy in refractory partial epilepsy: a double-blind, placebo-controlled, parallel-group study. Neurology. 43:1993;2292-2298.
22. The long-term safety and efficacy of gabapentin (Neurontin) as add-on therapy in drug-resistant partial epilepsy. Epilepsy Res. 18:1994;67-73.
23. Gabapentin in partial epilepsy. Lancet. 335:1990;1114-1117.